newborn that continuously monitors the necessary vital parameters used to detect Apnea , Hypothermia and other distress conditions . An integrated diagnostic tool that connects wirelessly to a central platform which ensures that the nurse can monitor all the babies simultaneously and alert when a distress condition is detected . It continuously tracks key vital parameters , detects distress conditions and alerts the caregiver for providing timely intervention and securely stores the data that can be accessed later by the doctor .
Nemocare sees the huge potential in the area as market size for baby monitoring devices is USD 1.2 billion for India alone . The Asia- Pacific and Indian baby monitor market is growing at 11 percent CAGR – owing to the rise in the amount of disposable income and number of working parents . There are 120,000 Hospitals ( private nursing homes and corporate Hospitals ) and 1500 public health centres that cater to 25 million babies that are born every year .
Key Milestones
Nemocare envisions to save the lives of 1 million newborns and soon be a part of India , rather the world where no baby ever dies of a cause that is completely preventable . The company is looking at establishing strong sales and distribution partners to penetrate
70 percent of the market in India .
In November 2017 , it got the first grant from the Melinda and Bill Gates Foundation for the Grand Challenges Exploration call and founders went on with small scale batch manufacturing and first employee recruitment .
During 2019 , Nemocare raised funds from the Biotech Ignition Grant ( BIG ) scheme of BIRAC for its 2nd product which will be used to harvest data and build predictive algorithms to predict the early onset of different critical disease states in newborns and allow the caregivers to take preventive action . During 2021 , NemoCare raised an undisclosed amount on Equity Assistance from Google for Startups and MassChallenge .
BIOVOICENEWS . COM 25